These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 9451426

  • 1. Impact of clinical and morphological variables in classification and regression tree-based survival (CART) analysis of CML with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Zirbes TK, Flucke U, Niederle N, Leder LD, Diehl V, Fischer R.
    Eur J Haematol; 1998 Jan; 60(1):35-46. PubMed ID: 9451426
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
    Thiele J, Zirbes TK, Lorenzen J, Kvasnicka HM, Dresbach S, Manich B, Leder LD, Niederle N, Diehl V, Fischer R.
    J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
    [Abstract] [Full Text] [Related]

  • 3. Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
    Thiele J, Kvasnicka HM, Titius BR, Parpert U, Nebel R, Zankovich R, Dienemann D, Stein H, Diehl V, Fischer R.
    Ann Hematol; 1993 Jun; 66(6):291-302. PubMed ID: 8318559
    [Abstract] [Full Text] [Related]

  • 4. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Schaefer HE.
    Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
    [Abstract] [Full Text] [Related]

  • 5. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Niederle N, Zirbes TK, Schmidt M, Dammasch J, Meuter BR, Leder LD, Kloke O, Diehl V.
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Zirbes TK, Birnbaum F, Kressmann C, Melguizo-Grahmann M, Frackenpohl H, Sprungmann C, Leder LD, Diehl V, Zankovich R, Schaefer HE, Niederle N, Fischer R.
    Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
    [Abstract] [Full Text] [Related]

  • 7. A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns.
    Thiele J, Wienhold S, Zankovich R, Fischer R.
    Anal Quant Cytol Histol; 1990 Apr; 12(2):103-16. PubMed ID: 2350386
    [Abstract] [Full Text] [Related]

  • 8. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
    Thiele J, Zirbes T, Kvasnicka HM, Niederle N, Dammasch J, Schmidt M, Windecker R, Leder LD, Diehl V, Fischer R.
    Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
    Kvasnicka HM, Thiele J, Schmitt-Graeff A, Diehl V, Zankovich R, Niederle N, Leder LD, Schaefer HE.
    J Clin Oncol; 2001 Jun 15; 19(12):2994-3009. PubMed ID: 11408494
    [Abstract] [Full Text] [Related]

  • 10. Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival.
    Thiele J, Hoefer M, Kvasnicka HM, Bertsch HP, Zankovich R, Fischer R.
    Hematol Pathol; 1993 Jun 15; 7(4):239-49. PubMed ID: 7906686
    [Abstract] [Full Text] [Related]

  • 11. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
    Thiele J, Zirbes TK, Kvasnicka HM, Lorenzen J, Niederle N, Leder LD, Fischer R.
    J Interferon Cytokine Res; 1996 Mar 15; 16(3):217-24. PubMed ID: 8697144
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
    Kvasnicka HM, Thiele J, Schmitt-Graeff A, Diehl V, Zankovich R, Niederle N, Leder LD, Schaefer HE.
    Br J Haematol; 2001 Mar 15; 112(3):727-39. PubMed ID: 11260078
    [Abstract] [Full Text] [Related]

  • 13. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.
    Thiele J, Kvasnicka HM, Niederle N, Kloke O, Schmidt M, Lienhard H, Zirbes T, Meuter RB, Leder LD, Fischer R.
    Am J Hematol; 1995 Sep 15; 50(1):30-9. PubMed ID: 7545352
    [Abstract] [Full Text] [Related]

  • 14. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Leder LD, Schaefer HE.
    Histopathology; 2000 Oct 15; 37(4):355-62. PubMed ID: 11012743
    [Abstract] [Full Text] [Related]

  • 15. Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters.
    Thiele J, Thienel C, Zankovich R, Fischer R.
    Med Oncol Tumor Pharmacother; 1988 Oct 15; 5(1):49-60. PubMed ID: 3163405
    [Abstract] [Full Text] [Related]

  • 16. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
    Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ, Thomas D, Cortes J, Andreeff M, Estrov Z, Rios MB, Albitar M.
    Cancer; 2001 Jun 01; 91(11):1964-72. PubMed ID: 11391574
    [Abstract] [Full Text] [Related]

  • 17. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis.
    Kvasnicka HM, Thiele J, Regn C, Zankovich R, Diehl V, Fischer R.
    Ann Hematol; 1999 Feb 01; 78(2):65-72. PubMed ID: 10089020
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of the histomorphometric features of bone marrow trephine biopsies in patients with chronic myeloid leukemia.
    Lamba A, Dey P, Kumari S, Marwaha N.
    Anal Quant Cytol Histol; 2007 Dec 01; 29(6):370-6. PubMed ID: 18225393
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Kriener S, Engels K, Staib P, Ollig ES, Keller C, Fokkema S, Griesshammer M, Waller CF, Ottmann OG, Hansmann ML.
    Histopathology; 2005 May 01; 46(5):540-50. PubMed ID: 15842636
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow trephine biopsy findings in chronic myeloid leukemia.
    Khonglah Y, Basu D, Dutta TK.
    Malays J Pathol; 2002 Jun 01; 24(1):37-43. PubMed ID: 16329554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.